Click here to learn more about Lexi from IQVIA</a>.<br /> <a rel="noopener noreferrer" href=https://www.iqvia.com/blogs/2020/06/"https://www.asyncapi.com/" target="_blank">Click here to learn more about the AsyncAPI initiative</a>.</p>" /> Click here to learn more about Lexi from IQVIA</a>.<br /> <a rel="noopener noreferrer" href=https://www.iqvia.com/blogs/2020/06/"https://www.asyncapi.com/" target="_blank">Click here to learn more about the AsyncAPI initiative</a>.</p>" />
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSIn order to drive tools to build modern, real-time applications that allow event-driven engagement with end customers, there was a need for an industry standard for defining asynchronous, event-driven APIs in a machine-readable format. Open-source project AsyncAPI is one such community where developers and industry leaders are working on these new tools.
AsyncAPI is an API documentation specification for how event-driven services communicate with one another. As an emerging language standard, IQVIA is a platinum sponsor of the project with the goal of changing the way businesses execute event processing via APIs. IQVIA and AsyncAPI share a common mission to standardize event-driven API interactions and support the wide variety of messaging systems available. IQVIA’s Lexi API standard vocabulary for the Life Sciences industry will align with AsyncAPI’s universal language for all the different messaging protocols and event schema formats. IQVIA joins two of its key technology partners MuleSoft and Salesforce in sponsoring the effort.
AsyncAPI founder Fran Mendez says that IQVIA is helping the open-source project to create a holistic solution for building event-driven apps and that event-driven APIs and the developing standard (AsyncAPI specification) can help companies evolve to event-driven thinking to solve problems in new ways.
AsyncAPI is important because it empowers more developers than ever before to unlock the value of events and asynchronous APIs, making IT architectures far more efficient than they are with request-response structures. “The real difference between the request-response paradigm and the event-driven world is that events and messages allow your system to be real-time and reactive, as opposed to waiting until a request from the client is made. The server pushes the update when the time is right, no request needed,” explains Mendez. The open-source nature of the AsyncAPI spec means it does not enforce any protocol, and it is interoperable with any messaging system, including MQTT, Kafka, WebSockets, and more. Fran emphasized “IQVIA’s Lexi initiative is a key step in the right direction for the Life Sciences industry to make event-driven communication accessible and easy to adopt. The future is event-driven, and IQVIA is in a good place to contribute to and leverage the AsyncAPI initiative for the benefit of its customers.”
IQVIA has been closely associated with the project and leverages the technology in its Lexi product. Lexi is an Application Programming Interface (API) layer that connects applications and data using a common vocabulary or lexicon. IQVIA has created a common lexicon for the life sciences industry which enables the creation of universal connectors for information exchanges across a network of internal and external applications.
Taking it a few steps further, Lexi powers a premier integration platform as a service (iPaaS) solution. Lexi is part of the platform’s mediation layer, where the data translated into the common Lexi vocabulary is evaluated, with a code look-up service and entity relationship service assisting with the identification and standardization of data record IDs. Lexi leverages best in class IPaaS technology to achieve full ecosystem orchestration. Key components of Lexi are the coordination layer (which houses the orchestration logic) and the mediation layer (which houses Lexicon that allows seamlessly translations between all applications in the ecosystem).
Lexi significantly reduces costs and simplifies the complexity of integrating technology systems, while capturing insights about markets, trends and opportunities that life sciences companies need for continued growth.
Lexi has been developed as an event driven architecture. AsyncAPI underlines this strategy and IQVIA is proud to support this innovative initiative. Lexi significantly reduces costs and simplifies the complexity of integrating applications. Historically, the maintenance of point-to-point (P2P) integrations among applications requires significant resources. Lexi modernizes the interconnectivity of proprietary applications, streamlines maintenance and improves speed to integration.
Click here to learn more about Lexi from IQVIA.
Click here to learn more about the AsyncAPI initiative.